Literature DB >> 26351222

Factors affecting survival of medulloblastoma in children: the changing concept of management.

Tai-Tong Wong1,2,3, Yen-Lin Liu4,5, Donald Ming-Tak Ho6, Kai-Ping Chang7, Muh-Lii Liang8, Hsin-Hung Chen8, Yi-Yen Lee8, Feng-Chi Chang9, Shih-Chieh Lin6, Ting-Rong Hsu7, Kuo-Wei Chen10, Wei-Kang Kwang11, Wu-Yu Hou12, Chung-Yih Wang13, Sang-Hue Yen14, Wan-You Guo8, Yi-Wei Chen15.   

Abstract

Medulloblastoma (MB) is a type of malignant tumor arising only in the cerebellum that was first defined by Cushing and Bailey in 1920s. In this review paper, we trace the evolution of risk stratification and the correlated changing concept of management in the past years. Outcome analysis of the hospital series of the Taipei Veterans General Hospital, Cheng Hsin General Hospital, and Taipei Medical University Hospital was performed to correlate prognostic indicators with reported studies. The purpose is to provide clues for age-specific and risk-adjusted optimal, effective, but beneficial and protective treatment strategies of these tumors in children.

Entities:  

Mesh：

Year:  2015        PMID： 26351222     DOI： 10.1007/s00381-015-2884-2

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN： 0256-7040            Impact factor:   1.475


  45 in total

1.  Harvey Cushing and medulloblastoma.

Authors:  Lara J Kunschner
Journal:  Arch Neurol       Date:  2002-04

2.  Medulloblastoma. A review of the LDS hospital experience.

Authors:  R C Brown; L Gunderson; H P Plenk
Journal:  Cancer       Date:  1977-07       Impact factor: 6.860

3.  The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone.

Authors:  A E Evans; R D Jenkin; R Sposto; J A Ortega; C B Wilson; W Wara; I J Ertel; S Kramer; C H Chang; S L Leikin
Journal:  J Neurosurg       Date:  1990-04       Impact factor: 5.115

4.  Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.

Authors:  David W Ellison; James Dalton; Mehmet Kocak; Sarah Leigh Nicholson; Charles Fraga; Geoff Neale; Anna M Kenney; Dan J Brat; Arie Perry; William H Yong; Roger E Taylor; Simon Bailey; Steven C Clifford; Richard J Gilbertson
Journal:  Acta Neuropathol       Date:  2011-01-26       Impact factor: 17.088

5.  Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children.

Authors:  Jacques Grill; Christian Sainte-Rose; Anne Jouvet; Jean-Claude Gentet; Odile Lejars; Didier Frappaz; François Doz; Xavier Rialland; Fabienne Pichon; Anne-Isabelle Bertozzi; Pascal Chastagner; Dominique Couanet; Jean-Louis Habrand; Marie-Anne Raquin; Marie-Cécile Le Deley; Chantal Kalifa
Journal:  Lancet Oncol       Date:  2005-08       Impact factor: 41.316

6.  Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.

Authors:  P M Zeltzer; J M Boyett; J L Finlay; A L Albright; L B Rorke; J M Milstein; J C Allen; K R Stevens; P Stanley; H Li; J H Wisoff; J R Geyer; P McGuire-Cullen; J A Stehbens; S B Shurin; R J Packer
Journal:  J Clin Oncol       Date:  1999-03       Impact factor: 44.544

7.  Combination chemotherapy with ifosfamide, cisplatin, and etoposide for medulloblastoma: single-institute experience and differences in efficacy for subgroups of medulloblastoma.

Authors:  Ryuta Saito; Toshihiro Kumabe; Yukihiko Sonoda; Masayuki Kanamori; Yoji Yamashita; Mika Watanabe; Teiji Tominaga
Journal:  Childs Nerv Syst       Date:  2011-05-18       Impact factor: 1.475

8.  Alex's Lemonade Stand Foundation Infant and Childhood Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011.

Authors:  Quinn T Ostrom; Peter M de Blank; Carol Kruchko; Claire M Petersen; Peter Liao; Jonathan L Finlay; Duncan S Stearns; Johannes E Wolff; Yingli Wolinsky; John J Letterio; Jill S Barnholtz-Sloan
Journal:  Neuro Oncol       Date:  2015-01       Impact factor: 12.300

9.  Medulloblastoma at the joint center for radiation therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival.

Authors:  E N Hughes; J Shillito; S E Sallan; J S Loeffler; J R Cassady; N J Tarbell
Journal:  Cancer       Date:  1988-05-15       Impact factor: 6.860

10.  Metastatic Medulloblastoma in Childhood: Chang's Classification Revisited.

Authors:  Christelle Dufour; Annick Beaugrand; Barry Pizer; Julie Micheli; Marie-Stephanie Aubelle; Aurelie Fourcade; Dominique Couanet; Agnes Laplanche; Chantal Kalifa; Jacques Grill
Journal:  Int J Surg Oncol       Date:  2011-09-11
View more
  6 in total

1.  Survival in pediatric medulloblastoma: a population-based observational study to improve prognostication.

Authors:  Alexander G Weil; Anthony C Wang; Harrison J Westwick; George M Ibrahim; Rojine T Ariani; Louis Crevier; Sebastien Perreault; Tom Davidson; Chi-Hong Tseng; Aria Fallah
Journal:  J Neurooncol       Date:  2016-12-15       Impact factor: 4.130

2.  Large cell/anaplastic medulloblastoma is associated with poor prognosis-a retrospective analysis at a single institute.

Authors:  Pin-I Huang; Shih-Chieh Lin; Yi-Yen Lee; Donald Ming-Tak Ho; Wan-Yuo Guo; Kai-Ping Chang; Feng-Chi Chang; Muh-Lii Liang; Hsin-Hung Chen; Yu-Ming Liu; Sang-Hue Yen; Tai-Tong Wong; Yi-Wei Chen
Journal:  Childs Nerv Syst       Date:  2017-05-09       Impact factor: 1.475

3.  Management, functional outcomes and survival in a French multicentric series of 118 adult patients with cerebellar glioblastoma.

Authors:  Luc Bauchet; Jacques Guyotat; Thiébaud Picart; David Meyronet; Johan Pallud; Chloé Dumot; Philippe Metellus; Sonia Zouaoui; Moncef Berhouma; François Ducray
Journal:  J Cancer Res Clin Oncol       Date:  2021-01-05       Impact factor: 4.553

4.  Enrichment of Tumor-Infiltrating B Cells in Group 4 Medulloblastoma in Children.

Authors:  Kuo-Sheng Wu; Ting-Yan Jian; Shian-Ying Sung; Chia-Ling Hsieh; Man-Hsu Huang; Chia-Lang Fang; Tai-Tong Wong; Yu-Ling Lin
Journal:  Int J Mol Sci       Date:  2022-05-09       Impact factor: 6.208

Review 5.  Modern management of medulloblastoma: Molecular classification, outcomes, and the role of surgery.

Authors:  Visish M Srinivasan; Michael G Z Ghali; Robert Y North; Zain Boghani; Daniel Hansen; Sandi Lam
Journal:  Surg Neurol Int       Date:  2016-12-28

6.  Molecular-Clinical Correlation in Pediatric Medulloblastoma: A Cohort Series Study of 52 Cases in Taiwan.

Authors:  Kuo-Sheng Wu; Donald Ming-Tak Ho; Shiann-Tarng Jou; Alice L Yu; Huy Minh Tran; Muh-Lii Liang; Hsin-Hung Chen; Yi-Yen Lee; Yi-Wei Chen; Shih-Chieh Lin; Feng-Chi Chang; Min-Lan Tsai; Yen-Lin Liu; Hsin-Lun Lee; Kevin Li-Chun Hsieh; Wen-Chang Huang; Shian-Ying Sung; Che-Chang Chang; Chun Austin Changou; Kung-Hao Liang; Tsung-Han Hsieh; Yun-Ru Liu; Meng-En Chao; Wan Chen; Shing-Shung Chu; Er-Chieh Cho; Tai-Tong Wong
Journal:  Cancers (Basel)       Date:  2020-03-11       Impact factor: 6.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.